A detailed history of Squarepoint Ops LLC transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 70,416 shares of VERA stock, worth $3.22 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
70,416
Previous 148,011 52.43%
Holding current value
$3.22 Million
Previous $5.36 Million 41.9%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$34.09 - $46.71 $2.65 Million - $3.62 Million
-77,595 Reduced 52.43%
70,416 $3.11 Million
Q2 2024

Aug 14, 2024

BUY
$33.72 - $48.82 $3.79 Million - $5.49 Million
112,475 Added 316.51%
148,011 $5.36 Million
Q1 2024

May 15, 2024

BUY
$14.91 - $49.14 $255,676 - $842,652
17,148 Added 93.26%
35,536 $1.53 Million
Q4 2023

Feb 14, 2024

BUY
$9.29 - $16.0 $170,824 - $294,208
18,388 New
18,388 $282,000
Q1 2023

May 15, 2023

BUY
$5.41 - $18.3 $357,687 - $1.21 Million
66,116 New
66,116 $513,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.24B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.